The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter

Slideshow IPOs

By The Online Investor Staff, updated Fri., Jul. 1, 5:47 AM

Slide #1. Syros Pharmaceuticals Initial Public Offering

Company: Syros Pharmaceuticals
Proposed Symbol: SYRS
Shares Offered: 4,000,000
Price Per Share: $12.50
Over-Allotment: 600,000
Description: Syros Pharmaceuticals today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share, before underwriting discounts and commissions. In addition, Syros has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock from Syros at the public offering price, less the underwriting discount and commissions, to cover over-allotments, if any. All of the shares are being offered by Syros Pharmaceuticals. The Company's shares are scheduled to begin trading on The NASDAQ Global Select Market on June 30, 2016 under the ticker symbol "SYRS." The offering is expected to close on July 6, 2016, subject to customary closing conditions.

IPOs: Syros Pharmaceuticals

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Midland States Bancorp, Inc.            MSBI      
Cotiviti Holdings, Inc.                 COTV      
US Foods Holding Corp.                  USFD      
GMS Inc.                                GMS       
Reata Pharmaceuticals, Inc.             RETA      
NantHealth, Inc.                        NH        
Clearside Biomedical, Inc.              CLSD      
Atkore International Group Inc.         ATKR      
China Online Education Group            COE       
Paragon Commercial Corporation          PBNC      
Paragon Commercial Corporation          PBNC      
Selecta Biosciences, Inc.               SELB      
Twilio Inc.                             TWLO      
Global Medical REIT Inc.                GMRE      
Syros Pharmaceuticals                   SYRS      

July 1, 2016    5:47 AM Eastern

IPOs | | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.